Japan, Feb. 24 -- BIOSCEPTRE AUST PTY LTD has got intellectual property rights for 'CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF.' Other related details are as follows:

Application Number: JP,2023-047606

Category (FI): A61K35/12,A61K35/17,A61K35/76,A61K39/395@E,A61K39/395@T,A61K40/10,A61K40/11,A61K40/15,A61K40/31,A61K40/42,A61K47/68,A61K48/00,A61P35/00,A61P35/02,C07K14/705,C07K16/28,C07K19/00,C12N15/115@Z,C12N15/13,C12N15/62@Z,C12N15/86@Z,C12N5/0783,C12N5/10

Stage: PROBLEM TO BE SOLVED: To provide a chimeric antigen receptor (CAR) targeting a tumour-associated antigen which is selectively expressed by cancerous cells but not endogenously expressed on non-cancerous cells.SOLUTION: A chimeric antigen receptor includes domains including an a...